Merit Medical Systems (MMSI) Given Daily Media Sentiment Rating of 0.30

News articles about Merit Medical Systems (NASDAQ:MMSI) have been trending positive this week, according to Accern Sentiment. The research group identifies negative and positive press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Merit Medical Systems earned a media sentiment score of 0.30 on Accern’s scale. Accern also assigned news coverage about the medical instruments supplier an impact score of 46.2332581288169 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

A number of equities research analysts have issued reports on the company. BidaskClub downgraded Merit Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, January 26th. ValuEngine downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Canaccord Genuity boosted their price target on Merit Medical Systems from $45.00 to $47.50 and gave the company a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, January 25th. Finally, SunTrust Banks set a $47.00 target price on Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $43.77.

Shares of Merit Medical Systems (MMSI) traded up $0.55 during midday trading on Friday, hitting $42.65. The stock had a trading volume of 257,115 shares, compared to its average volume of 257,498. Merit Medical Systems has a 52 week low of $27.08 and a 52 week high of $48.10. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. The stock has a market capitalization of $2,140.99, a P/E ratio of 69.92, a price-to-earnings-growth ratio of 2.53 and a beta of 1.29.

In related news, Director Franklin J. Miller sold 10,000 shares of the business’s stock in a transaction dated Friday, December 29th. The stock was sold at an average price of $43.93, for a total value of $439,300.00. Following the transaction, the director now owns 21,244 shares in the company, valued at $933,248.92. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Kent W. Stanger sold 2,918 shares of the business’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $44.55, for a total value of $129,996.90. The disclosure for this sale can be found here. Insiders sold 32,000 shares of company stock valued at $1,416,379 in the last ninety days. Company insiders own 5.00% of the company’s stock.

WARNING: This report was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://ledgergazette.com/2018/02/12/merit-medical-systems-mmsi-receiving-favorable-press-coverage-study-finds.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply